These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26019089)

  • 21. Drug-induced hair colour changes.
    Ricci F; De Simone C; Del Regno L; Peris K
    Eur J Dermatol; 2016 Dec; 26(6):531-536. PubMed ID: 27545142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The morphological signs of hair disease in children poisoned by thallium and boron].
    Pavlov IuV; Alisievich VI
    Sud Med Ekspert; 1995; 38(2):20-1. PubMed ID: 7638883
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiotoxicity associated with sunitinib.
    Hariharan S; Lowry S
    Lancet; 2008 Apr; 371(9620):1244-5; author reply 1245. PubMed ID: 18406854
    [No Abstract]   [Full Text] [Related]  

  • 24. Green hair: treatment with a penicillamine shampoo.
    Person JR
    Arch Dermatol; 1985 Jun; 121(6):717-8. PubMed ID: 4004298
    [No Abstract]   [Full Text] [Related]  

  • 25. Efficacy of sunitinib and sorafenib in non-clear cell renal cell carcinoma: results from expanded access studies.
    Strumberg D
    J Clin Oncol; 2008 Jul; 26(20):3469-71; author reply 2471. PubMed ID: 18612169
    [No Abstract]   [Full Text] [Related]  

  • 26. Sunitinib-induced pseudoporphyria.
    Sanz-Motilva V; Martorell-Calatayud A; Llombart B; Requena C; Serra-Guillén C; Nagore E; Guillén C; Traves V; Sanmartín O
    J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1848-50. PubMed ID: 24813651
    [No Abstract]   [Full Text] [Related]  

  • 27. Acute hepatic failure following monotherapy with sunitinib for ovarian cancer.
    Taran A; Ignatov A; Smith B; Costa SD; Bischoff J
    Cancer Chemother Pharmacol; 2009 Apr; 63(5):971-2. PubMed ID: 18716778
    [No Abstract]   [Full Text] [Related]  

  • 28. Sunitinib-induced acute psychosis: case report.
    Kunene V; Porfiri E
    Clin Genitourin Cancer; 2011 Sep; 9(1):70-2. PubMed ID: 21729680
    [No Abstract]   [Full Text] [Related]  

  • 29. Sunitinib-associated thrombotic microangiopathy: a significant risk.
    Buckley FD; Preston G; Meiklejohn DJ; Adamson D
    Clin Oncol (R Coll Radiol); 2014 Aug; 26(8):515. PubMed ID: 24746506
    [No Abstract]   [Full Text] [Related]  

  • 30. Response to 'Thyrotoxicosis during sunitinib treatment for renal cell carcinoma' by Grossmann et al.
    Daniels GH
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):455. PubMed ID: 19138312
    [No Abstract]   [Full Text] [Related]  

  • 31. [New drugs; sunitinib and sorafenib].
    Bellersen L
    Ned Tijdschr Geneeskd; 2008 Feb; 152(8):469-70; author reply 470. PubMed ID: 18363211
    [No Abstract]   [Full Text] [Related]  

  • 32. New targets, therapies, and toxicities: lessons to be learned.
    Stadler WM
    J Clin Oncol; 2006 Jan; 24(1):4-5. PubMed ID: 16314613
    [No Abstract]   [Full Text] [Related]  

  • 33. A CT scan aspect of "hypodense thyroid gland" after sunitinib treatment for metastatic carcinoma of the kidney.
    Vélayoudom-Céphise FL; Vian E; Bosewa T; Nallet E; Wemeau JL; Donnet JP
    J Clin Endocrinol Metab; 2011 Mar; 96(3):590-1. PubMed ID: 21378222
    [No Abstract]   [Full Text] [Related]  

  • 34. [Erlotinib, sunitinib, and everolimus].
    Takahashi M
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():409-13. PubMed ID: 25857058
    [No Abstract]   [Full Text] [Related]  

  • 35. Fatal liver failure in a patient treated with sunitinib for renal cell carcinoma.
    Mermershtain W; Lazarev I; Shani-Shrem N; Ariad S
    Clin Genitourin Cancer; 2013 Mar; 11(1):70-2. PubMed ID: 23063577
    [No Abstract]   [Full Text] [Related]  

  • 36. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate.
    Nicholaou T; Wong R; Davis ID
    Lancet; 2007 Jun; 369(9577):1923-4. PubMed ID: 17560435
    [No Abstract]   [Full Text] [Related]  

  • 37. Green hair: guidelines for diagnosis and therapy.
    Melnik BC; Plewig G; Daldrup T; Borchard F; Pfeiffer B; Zahn H
    J Am Acad Dermatol; 1986 Nov; 15(5 Pt 1):1065-8. PubMed ID: 3782531
    [No Abstract]   [Full Text] [Related]  

  • 38. When a thymic carcinoma "becomes" a GIST.
    Rossi V; Donini M; Sergio P; Passalacqua R; Rossi G; Buti S
    Lung Cancer; 2013 Apr; 80(1):106-8. PubMed ID: 23375402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lung Aspergillosis in renal cell carcinoma patient treated with sunitinib.
    Visvardis EE; Gao F; Paes MN; Duprez O; Waxman J
    QJM; 2012 Jul; 105(7):689-92. PubMed ID: 21693543
    [No Abstract]   [Full Text] [Related]  

  • 40. Sunitinib-induced hemoglobin changes are related to the dosing schedule.
    van der Veldt AA; Boven E; Vroling L; Broxterman HJ; van den Eertwegh AJ; Haanen JG
    J Clin Oncol; 2009 Mar; 27(8):1339-40; author reply 1340-2. PubMed ID: 19188672
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.